Spit-stimulating natural compounds could end dry mouth
Dry mouth might not seem like a pressing concern in the middle of a pandemic. However,the condition affects between 10% and 30% of adults and seniors — most often as a side effect of radiation therapy for head and neck cancers or as a symptom of autoimmune diseases such as Sjögren’s syndrome — and can increase a patient’s risk of developing dental decay, tooth demineralization and oral infections.
than capsaicin.
In a step toward developing drugs that might treat dry mouth, or xerostomia, researchers at King’s College London performed a nonbiased proteomics analysis of the effects that various natural compounds have on the channels of chemesthetic transient receptors, also known as TRP channels, expressed on the mucosal membrane that lines the inside of the mouth. They published their detailing the compounds’ influence on the flow and protein composition of saliva in the journal Molecular & Cellular Proteomics.
The proteomics analysis was the product of a collaboration between , now a postdoctoral researcher at a University of Cambridge proteomics facility, and the lab of , a professor of salivary biology at King’s College London.
“The group has been studying dry mouth from a number of different angles for several years,” Houghton said. “But ultimately, it’s quite an open question still because it’s not just a lack of saliva, it’s also the quality or the content of the saliva that changes, and these changes cause differences in how flavors adhere to the mucosal surfaces in the mouth.”
Where saliva comes from is also a key distinction. The human mouth contains three major salivary glands — the parotid far behind the molars, the sublingual below the tongue and the submandibular beneath the mandibles — and close to 1,000 minor glands dotted across the tongue, palate and lips.
“There are hundreds of minor salivary glands in the lip — you can kind of feel them if you rub your tongue against your lip, the little hard, circular balls,” Houghton said. “We are interested in these minor glands because they are within the mucosal surfaces where we thought that we might see differences or changes in how this saliva adheres.”
Houghton and colleagues applied multibatch quantitative mass spectrometryto saliva collected from volunteers who had rinsed their mouths with a TRP agonist. They found that nonivamide, a capsaicinlike agonist of the TRPV1 channel that is naturally found in chile peppers, and menthol, an agonist of the TRMP8 channel, both caused an increase in the secretion of digestive proteins and the flow of saliva in all parts of volunteers’ mouths, including the minor glands. As both compounds are alkaloids, they would not carry the same risks as acidic tastants that stimulate salivary secretion but erode enamel tissues.
This expands on previous findings that agonists of salivary channels such as piperine, an alkaloid found in black peppers, and capsaicin, the active compound in chile peppers that has been explored for its role in mitigating , and , are able to increase the flow of saliva in patients’ mouths.
Houghton and his colleagues plan to examine the mechanisms the TRP agonists use to modify the rheological properties of saliva. Fortunately, the saliva they’ll be analyzing was collected two years ago – long before the COVID-19 pandemic limited access to both research labs and willing volunteers.
“The next steps have already been carried out, but haven’t been published yet,” Houghton said. “They are essentially further investigations into the direct stimulation of the saliva gland cells by the TRP agonists.”
Enjoy reading 91ÑÇÉ«´«Ã½ Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from 91ÑÇÉ«´«Ã½ Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
New discovery enables gene therapy for muscular dystrophies, other disorders
At the University of Rochester, researchers find that RNA-based technology facilitates effective use for difficult-to-treat, large-gene diseases.
From the journals: JBC
Huntington protein interactions affect aggregation. Intrinsically disordered protein forms a scaffold. From unknown protein to curbing cancer growth. Read about recent JBC papers on these topics.
An inclusive solar eclipse — with outreach
Traveling more than 150 miles with a group of neurodivergent students to have them witness a rare orbital alignment. and also teach the public about it, requires some strategic planning.
Predicting fatty liver disease from a tiny blood sample
Obesity and being overweight aren't the only factors that contribute to liver disease. New tests can help identify who is at risk or already has the disease, even in people who are lean or have a normal weight.
An ancient animal helps scientists improve modern technology
The same molecules that help tardigrades survive extreme weather can improve cryo-EM images of cellular structures and proteins, a team led by University of Wisconsin–Madison researcher Ci Ji Lim reports.
New structure gives insight into mRNA export and cancers
Yi Ren’s lab at Vanderbilt has described the structure of a protein complex that sheds light on the underlying molecular mechanism of mRNA export.